REGENEREX PHARMA, INC (RGPX) Net income 2013–2024
REGENEREX PHARMA, INC (RGPX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$2.5MFY2024 · since FY2013: $859,827 → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.5M | +28.7% |
| FY2023 | -$3.5M | -2480.5% |
| FY2022 | -$137,330 | +29.8% |
| FY2021 | -$195,591 | +44.7% |
| FY2020 | -$353,752 | -417.0% |
| FY2019 | $111,589 | +219.2% |
| FY2018 | -$93,579 | -88.4% |
| FY2017 | -$49,671 | -1830.5% |
| FY2016 | -$2,573 | — |
| FY2013 | $859,827 | — |
Source: SEC XBRL filings · For reference only · Not investment advice